ClinVar Miner

Submissions for variant NM_000277.3(PAH):c.1099del (p.Leu367fs)

dbSNP: rs62506951
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PAH Variant Curation Expert Panel RCV000781680 SCV002818507 pathogenic Phenylketonuria 2022-07-30 reviewed by expert panel curation The frameshift variant c.1099del (HGVS nomenclature c.1095del) occurs in exon 11 of 13 and is predicted to result in NMD. The variant is found at an extremely low allele frequency of 0.000003980 overall in gnomAD with a MAF of 0.000008804 (1/113590) in the European population. One classical PKU patient has been reported (PMID: 29176022) with this variant in trans with Arg241Cys (ClinVar 102803, Pathogenic with expert panel review). In summary, this variant meets criteria to be classified as Pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3_supporting, PP4_moderate.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781680 SCV000919922 likely pathogenic Phenylketonuria 2018-08-27 criteria provided, single submitter clinical testing Variant summary: PAH c.1099delC (p.Leu367TrpfsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4.1e-06 in 245994 control chromosomes. c.1099delC has been reported in the literature in individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV000781680 SCV001199465 pathogenic Phenylketonuria 2021-03-10 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Leu367Trpfs*33) in the PAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAH are known to be pathogenic (PMID: 1301187, 9634518). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individual(s) with hyperphenylalaninemia (PMID: 29176022, 29499199). ClinVar contains an entry for this variant (Variation ID: 102524). For these reasons, this variant has been classified as Pathogenic.
DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE RCV000088757 SCV000119341 not provided not provided no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.